Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Gynecol Oncol. 2012 Aug 29;127(3):544–551. doi: 10.1016/j.ygyno.2012.08.031

Table 2.

Factors associated with fulfillment of endometrial cancer (EC) risk-reducing guidelinesa among women at risk for Lynch syndrome (LS)-associated EC (Cohort 1 - cross-sectional cohort)

Variable Fulfilling guidelines a
Number (row %)
Not fulfilling guidelines a
Number (row %)
P valueb
Total cohort 1 (N=77) 58 (75) 19 (25)
Demographics
Mean age (± SD) 39.5 ± 11.1 47.3 ±9.9 0.01
   <40 Years old 30 (86) 5 (14) 0.04
   40–49 Years old 18 (75) 6 (25)
   ≥50 Years old 9 (53) 8 (47)
   Unknown/missing 1(--) 0(--)
Educational level
   Less than college graduate 14 (61) 9 (39) 0.08
   At least college graduate 44 (81) 10 (19)
Annual income
   <$50,000 12 (80) 3 (20) 0.75
   ≥$50,000 42 (74) 15 (26)
   Unknown/missing 4(--) 1(--)
Marital status
   Married 46 (79) 12 (21) 0.13
   Not married 11 (61) 7 (39)
   Unknown/missing 1 (--) 0 (--)
Personal history and
health practices
Personal cancer history
   Have had any cancer 25 (83) 5 (17) 0.28
   Have not had any cancer 33 (70) 14 (30)
Personal colorectal
cancer (CRC) history
   Have had CRC 22 (81) 5 (19) 0.42
   Have not had CRC 36 (72) 14 (28)
Physician visits in the
past year
   0 1 (100) 0 (0) 0.82
   1–6 44 (76) 14 (24)
   ≥7 13 (72) 5 (28)
Physician discussed
cancer risk
   Yes 48 (73) 18 (27) 0.28
   No 10 (91) 1 (9)
CRC surveillance
practicesc
   Adequate CRC surveillancec 47 (85) 8 (15) 0.03
   Inadequate CRC surveillancec 11 (50) 11 (50)
Family history
Fulfills Amsterdam
Criteria
   Yes 48 (74) 17 (26) 0.72
   No 10 (83) 2 (17)
Known MMR mutation
in the family
   Yes 42 (86) 7 (14) 0.01
   No 16 (57) 12 (43)
1st/2nd degree relative
with EC
   Yes 27 (82) 6 (18) 0.30
   No 31 (70) 13 (30)
Genetic evaluation
Visited high-risk clinic
   Yes 52 (81) 12 (19) 0.01
   No 6 (46) 7 (54)
Genetic testing status
   Had genetic testing 51 (88) 7 (12) <0.001
   Have not had genetic testing 7 (37) 12 (63)
Genetic test result
   Positive 42 (93) 3 (7) 0.04
   Indeterminate/variant 9 (69) 4 (31)
a

“Fulfilling guidelines” defined as either (1) having had a prophylactic hysterectomy, (2) reporting annual EC surveillance by transvaginal ultrasound and/or endometrial biopsy, and/or (3) age <35 years old

b

Fisher’s exact test was used for categorical values, and t-test was used for continuous variables

c

“Adequate colorectal cancer surveillance” defined as having colonoscopy at least every 2 years or being age <25